Outcomes of patients with primary refractory multiple myeloma in the era of triplet and quadruplet induction therapy

por Charalampous, Charalampos, Goel, Utkarsh, Kapoor, Prashant, Binder, Moritz, Buadi, Francis K., Cook, Joselle, Dingli, David, Dispenzieri, Angela, Fonder, Amie L., Gertz, Morie A., Gonsalves, Wilson, Hayman, Suzanne R., Hobbs, Miriam A., Hwa, Yi L., Kourelis, Taxiarchis, Lacy, Martha Q., Leung, Nelson, Lin, Yi, Warsame, Rahma, Kyle, Robert A., Rajkumar, S. Vincent, Kumar, Shaji K.
Publicado 2023

Venetoclax for the treatment of translocation (11;14) AL amyloidosis

por Sidiqi, M. Hasib, Al Saleh, Abdullah S., Leung, Nelson, Jevremovic, Dragan, Aljama, Mohammed A., Gonsalves, Wilson I., Buadi, Francis K., Kourelis, Taxiarchis V., Warsame, Rahma, Muchtar, Eli, Hobbs, Miriam A., Lacy, Martha Q., Dingli, David, Go, Ronald S., Hayman, Suzanne R., Rajkumar, S. Vincent, Dispenzieri, Angela, Gertz, Morie A., Kumar, Shaji K., Fonseca, Rafael, Kapoor, Prashant
Publicado 2020

Defining drug/drug class refractoriness vs lines of therapy in relapsed/refractory multiple myeloma

por Goel, Utkarsh, Charalampous, Charalampos, Kapoor, Prashant, Binder, Moritz, Buadi, Francis K., Dingli, David, Dispenzieri, Angela, Fonder, Amie, Gertz, Morie A., Gonsalves, Wilson I., Hayman, Suzanne R., Hobbs, Miriam A., Hwa, Yi L., Kourelis, Taxiarchis, Lacy, Martha Q., Leung, Nelson, Lin, Yi, Warsame, Rahma M., Kyle, Robert A., Rajkumar, S. Vincent, Kumar, Shaji K.
Publicado 2023

The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?

por Sidiqi, M. Hasib, Aljama, Mohammed, Kumar, Shaji K., Jevremovic, Dragan, Buadi, Francis K., Warsame, Rahma, Lacy, Martha Q., Dingli, David, Gonsalves, Wilson I., Fonder, Amie L., Hobbs, Miriam A., Hwa, Yi Lisa, Kapoor, Prashant, Kourelis, Taxiarchis, Leung, Nelson, Muchtar, Eli, Lust, John A., Kyle, Robert A., Go, Ronald S., Rajkumar, Vincent S., Gertz, Morie A., Dispenzieri, Angela
Publicado 2020

Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria

por Lakshman, Arjun, Rajkumar, S. Vincent, Buadi, Francis K., Binder, Moritz, Gertz, Morie A., Lacy, Martha Q., Dispenzieri, Angela, Dingli, David, Fonder, Amie L., Hayman, Suzanne R., Hobbs, Miriam A., Gonsalves, Wilson I., Hwa, Yi Lisa, Kapoor, Prashant, Leung, Nelson, Go, Ronald S., Lin, Yi, Kourelis, Taxiarchis V., Warsame, Rahma, Lust, John A., Russell, Stephen J., Zeldenrust, Steven R., Kyle, Robert A., Kumar, Shaji K.
Publicado 2018

Natural history of multiple myeloma with de novo del(17p)

por Lakshman, Arjun, Painuly, Utkarsh, Rajkumar, S. Vincent, Ketterling, Rhett P., Kapoor, Prashant, Greipp, Patricia T., Gertz, Morie A., Buadi, Francis K., Lacy, Martha Q., Dingli, David, Dispenzieri, Angela, Fonder, Amie L., Hayman, Suzanne R., Hobbs, Miriam A., Gonsalves, Wilson I., Hwa, Yi Lisa, Leung, Nelson, Go, Ronald S., Lin, Yi, Kourelis, Taxiarchis V., Warsame, Rahma, Lust, John A., Russell, Stephen J., Zeldenrust, Steven R., Kyle, Robert A., Kumar, Shaji K.
Publicado 2019

A simple additive staging system for newly diagnosed multiple myeloma

por Abdallah, Nadine H., Binder, Moritz, Rajkumar, S. Vincent, Greipp, Patricia T., Kapoor, Prashant, Dispenzieri, Angela, Gertz, Morie A., Baughn, Linda B., Lacy, Martha Q., Hayman, Suzanne R., Buadi, Francis K., Dingli, David, Go, Ronald S., Hwa, Yi L., Fonder, Amie L., Hobbs, Miriam A., Lin, Yi, Leung, Nelson, Kourelis, Taxiarchis, Warsame, Rahma, Siddiqui, Mustaqeem A., Kyle, Robert A., Bergsagel, P. Leif, Fonseca, Rafael, Ketterling, Rhett P., Kumar, Shaji K.
Publicado 2022

Patients with Monoclonal Gammopathy Have a High Rate of Second Symptomatic COVID-19 Infection Even after a Prior COVID-19 Infection and Vaccination

por Zanwar, Saurabh, Ho, Matthew, Buadi, Francis K., Ailawadhi, Sikander, Larsen, Jeremy T., Bergsagel, P. Leif, Binder, Moritz, Chanan-Khan, Asher, Dingli, David, Dispenzieri, Angela, Fonseca, Rafael, Gertz, Morie A., Gonsalves, Wilson I., Go, Ronald, Hayman, Suzanne R., Kapoor, Prashant, Kourelis, Taxiarchis, Lacy, Martha Q., Leung, Nelson, Lin, Yi, Muchtar, Eli, Roy, Vivek, Sher, Taimur, Warsame, Rahma M, Fonder, Amie, Hobbs, Miriam A., Hwa, Yi L., Kyle, Robert A., Rajkumar, S. Vincent, Kumar, Shaji K
Publicado 2022

Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement

por Gonsalves, Wilson I., Buadi, Francis K., Ailawadhi, Sikander, Bergsagel, P. Leif, Chanan Khan, Asher A., Dingli, David, Dispenzieri, Angela, Fonseca, Rafael, Hayman, Susan R., Kapoor, Prashant, Kourelis, Taxiarchis V., Lacy, Martha Q., Larsen, Jeremy T., Muchtar, Eli, Reeder, Craig B., Sher, Taimur, Stewart, A. Keith, Warsame, Rahma, Go, Ronald S., Kyle, Robert A., Leung, Nelson, Lin, Yi, Lust, John A., Russell, Stephen J., Zeldenrust, Stephen R., Fonder, Amie L., Hwa, Yi L., Hobbs, Miriam A., Mayo, Angela A., Hogan, William J., Rajkumar, S. Vincent, Kumar, Shaji K., Gertz, Morie A., Roy, Vivek
Publicado 2018